Keyphrases
Childhood Acute Lymphoblastic Leukemia
100%
Adrenal Insufficiency
100%
Glucocorticoid Therapy
100%
Hypothalamic-pituitary-adrenal Axis Suppression
100%
Randomized Controlled Trial
36%
First Day
27%
Fluconazole
27%
Prednisone
27%
Review Authors
27%
Risk Factors
18%
Risk of Bias
18%
Pituitary
18%
HPA Axis
18%
Hypothalamus
18%
Glucocorticoid Replacement Therapy
18%
Pediatric Oncology
9%
Acute Lymphoblastic Leukemia
9%
International Society
9%
Selection Criteria
9%
PubMed
9%
Number of children
9%
Embase
9%
Stress Response
9%
MEDLINE
9%
Pediatric Hematology
9%
Antifungal Drugs
9%
Life-threatening Complications
9%
Evidence-based Guidelines
9%
National Institutes of Health
9%
Ongoing Trials
9%
Issue 11
9%
Ovid
9%
World Health Organization
9%
International Clinical Trials Registry Platform (ICTRP)
9%
Conference Proceedings
9%
Cochrane Central Register of Controlled Trials
9%
Health Registers
9%
Adrenal Function
9%
Cortisol Reactivity
9%
First Week
9%
High-quality Research
9%
Host Defense
9%
American Society of Clinical Oncology
9%
Extracted Data
9%
Search Methods
9%
Second-line Treatment
9%
Cochrane Review
9%
American Society
9%
Prolonged Duration
9%
Hypothalamic-pituitary-adrenal Axis Function
9%
Social Studies
9%
Supraphysiological
9%
Medicine and Dentistry
Acute Lymphoblastic Leukemia
100%
Glucocorticoid
100%
Hypothalamic-Pituitary-Adrenal Axis
100%
Adrenal Insufficiency
100%
Infection
45%
Randomized Controlled Trial
36%
Dexamethasone
27%
Prednisone
27%
Fluconazole
27%
Drug Megadose
18%
Hypothalamus
18%
Substitution Therapy
18%
Childhood Cancer
9%
Clinical Trial
9%
Oncology
9%
Observational Study
9%
Arm
9%
Clinician
9%
Pediatric Hematology
9%
Adrenal Function
9%
Hydrocortisone
9%
Antifungal Agent
9%
Host Resistance
9%
Clinical Oncology
9%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Lymphoblastic Leukemia
100%
Glucocorticoid
100%
Adrenal Insufficiency
100%
Infection
45%
Randomized Controlled Trial
36%
Dexamethasone
27%
Fluconazole
27%
Prednisone
27%
Replacement Therapy
18%
Clinical Trial
9%
Childhood Cancer
9%
Antifungal Agent
9%
Observational Study
9%
Hydrocortisone
9%
Neuroscience
Glucocorticoid
100%
Hypothalamic-Pituitary-Adrenal Axis
100%
Adrenal Insufficiency
100%
Randomized Controlled Trial
36%
Dexamethasone
27%
Prednisone
27%
Fluconazole
27%
Hypothalamus
18%
Cortisol
9%
Antifungal
9%